美国司法部副助理总检察长Jacob Foster在STAT峰会上宣布,DOJ正为药企建立主动报告潜在违规问题的新路径。今后企业只需向DOJ披露一次,即可同时获得DOJ的刑事不起诉和HHS的财务处罚及酌情排除减免;HHS也将更新流程,明确潜在刑事不当行为应向DOJ而非HHS披露。Foster称此举旨在鼓励这一重要美国行业的创新。
At the STAT Summit, Jacob Foster, a deputy assistant attorney general at the U.S. Department of Justice, made some news.
The DOJ is creating a new pathway for companies to report issues that might get them in trouble before they get caught.
"The two doors, they end today. Going forward, one disclosure to the Department of Justice will obtain the benefits of both the department's program, which is a criminal declination, and HHS's the limit on financial penalties and the limit on permissive exclusion. And HHS is updating its protocol to solve the converse problem, clarifying that in instances of potential criminal misconduct, you should disclose to the department and not to HHS.
"Why is this important? Because it's in the department's interest to encourage innovation in this incredibly important American industry."
Full video here.
来源:Matthew Herper · x.com